Forward Pharma A/S announced consolidated unaudited earnings results for the first quarter ended March 31, 2016. For the quarter, the company reported net loss of $16,851,000 or $0.36 per diluted share compared with net income of $6,026,000 or $0.12 per diluted share for the same period a year ago. Non-GAAP net loss of $8,989,000 or $0.19 per diluted share compared with $6,115,000 or $0.12 per diluted share for the same period a year ago. Operating loss was $12,640,000 compared to $8,389,000 a year ago. Net cash flows used in operating activities was $8,880,000 compared to $5,081,000 a year ago.